Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Drug Monitoring for Optimized Outcome in Patients With Metastatic Renal Cell Carcinoma

NCT04659343 is registered in ClinicalTrials.gov with Niels Fristrup as lead sponsor.

NCT NCT04659343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04659343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Drug Monitoring for Optimized Outcome in Patients With Metastatic Renal Cell Carcinoma
Lead sponsor
Niels Fristrup
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2020
Completion date
August 31, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug mechanism, drug side effect, drug toxicity, kidney cancer, renal cell carcinoma metastatic